| 1 |
A Study on Global Clinical Approval of Exosome-Based Therapeutics Loaded with Anti-inflammatory Proteins for Treatment of ***** |
| Other-Bio. |
**** |
**** |
Preclinical |
ILIAS Biologics Inc. |
RS-2025-25444945 |
|
| 2 |
Exosome-Based Therapy for Chronic Kidney Disease: Preclinical and IND-Enabling Studies |
| Other-Bio. |
CKD |
Super repressor IκB |
Preclinical |
ILIAS Biologics Inc. |
RS-2025-02073027 |
|
| 3 |
Development of TMAU Treatment through FDA Rare Disease Designation and IND Approval |
| Other-Bio. |
Trimethylaminuria |
TMA |
Preclinical |
BioMe, Inc. |
RS-2024-00443597 |
|
| 4 |
Study on the Discovery of Lead Compounds for Lesch-Nyhan Syndrome Treatment Using Cell-Derived Vesicles Carrying HPRT1 mRNA and Proteins |
| Other-Bio. |
Lesch-Nyhan syndrome |
HPRT1 |
Lead |
MDimune Inc. |
RS-2024-00337778 |
|
| 5 |
Mitochondrial transplantation as a novel treatment for sensorineural hearing loss |
| Other-Bio. |
Hearing loss |
Sensorineural hearing loss (with mitochondrial defects) |
Candidate |
Paean Biotechnology Inc. |
RS-2023-00283926 |
|